Deals in Depth: January 2009
Executive Summary
January 2009 dealmaking highlights: Big Pharma consolidation is back in the news as one of the largest mega-mergers in history took place in January with Pfizer's acquisition of Wyeth for $67bn. Abbott topped the list on the device side, leaping into the vision care field with its $2.8bn purchase of Advanced Medical Optics. Meanwhile financing--mainly from private placements--for both the drug and device industries was up from the previous month, and notably pharma showed a 4x increase in private investor funding.
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.